Suppr超能文献

慢性完全闭塞性冠状动脉病变患者经皮冠状动脉介入治疗对血管内皮细胞激活和凝血酶生成的影响。

Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion.

机构信息

Department of Cardiology and Cardiac Surgery, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, Hungary; Doctoral School of Kálmán Laki, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, Hungary.

Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98., H-4032 Debrecen, Hungary.

出版信息

Thromb Res. 2022 Sep;217:64-72. doi: 10.1016/j.thromres.2022.07.010. Epub 2022 Jul 23.

Abstract

BACKGROUND

Percutaneous coronary intervention (PCI) is commonly used treatment for chronic total occlusion (CTO). PCI can be performed in two different ways using wire escalation (WE) or subintimal dissection and reentry (DR) technique. During both procedures patients are treated with anticoagulants, however a substantial activation of coagulation cascade is expected, which may affect clinical outcome.

OBJECTIVES

Our aim was to compare the impact of WE and DR techniques regarding endothelial cell activation and thrombin formation.

METHODS

Fifty patients after CTO-PCI were enrolled into this study. Blood samples were obtained before PCI, at 48 h and 3-6 months after the intervention to measure soluble endothelium-specific markers and to investigate thrombin generation.

RESULTS

Twenty-nine patients were treated with WE, 21 received DR. In the DR group, soluble VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular cell adhesion molecule-1) concentrations were gradually elevated and remained significantly increased at 3-6 months (p = 0.006 and p = 0.037, respectively) compared to pre-PCI. Furthermore, significant decrease in lagtime (p = 0.004) and time to peak (p = 0.002) with a substantial increment in peak thrombin (p = 0.001) were observed in these patients. In contrast, no significant alteration was found in the WE cohort. Clinical complications (myocardial infarction, stroke, thrombosis, revascularization) did not occur in the first 9 months of follow-up period in either group.

CONCLUSION

Although DR intervention induces more thrombin generation with a larger degree of endothelium activation compared to WE, this technique does not cause more clinical complications.

摘要

背景

经皮冠状动脉介入治疗(PCI)是治疗慢性完全闭塞(CTO)的常用方法。可以通过导丝升级(WE)或内膜下夹层和再进入(DR)技术以两种不同的方式进行 PCI。在这两种操作中,患者都接受抗凝治疗,但预计凝血级联会被大量激活,这可能会影响临床结果。

目的

我们旨在比较 WE 和 DR 技术对内皮细胞激活和凝血酶形成的影响。

方法

本研究纳入了 50 例 CTO-PCI 后的患者。在 PCI 前、48 小时和干预后 3-6 个月采集血样,以测量可溶性内皮细胞特异性标志物并研究凝血酶生成。

结果

29 例患者接受 WE 治疗,21 例接受 DR 治疗。在 DR 组中,可溶性 VCAM-1(血管细胞黏附分子-1)和 ICAM-1(细胞间黏附分子-1)浓度逐渐升高,与 PCI 前相比,在 3-6 个月时仍显著升高(p=0.006 和 p=0.037)。此外,这些患者的 lagtime(p=0.004)和 time to peak(p=0.002)显著缩短,而峰值凝血酶显著增加(p=0.001)。相比之下,WE 组没有发现明显变化。在随访的前 9 个月内,两组均未发生临床并发症(心肌梗死、中风、血栓形成、血运重建)。

结论

尽管与 WE 相比,DR 干预会导致更多的凝血酶生成和更大程度的内皮细胞激活,但这种技术不会导致更多的临床并发症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验